Stock daily read

What happened with YCBD today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

YCBD in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

cbdMD sells products for consumers seeking help with sleep, recovery, mood and other wellness needs. Its cbdMD brand sells cannabidiol (CBD) products for people, while Paw CBD serves pet owners. It also sells functional mushroom supplements under ATRx Labs and hemp-derived THC beverages under Herbal Oasis, where permitted.

Consumers buying online provide most of its revenue. Retailers and distributors also buy its products for resale, with beverage distributors helping Herbal Oasis reach stores. This reliance on online sales makes attracting new customers at an affordable cost important; advertising-platform rules and algorithms can limit its ability to reach them.

The business also depends on which hemp products regulators allow it to sell. Full-spectrum products, which contain CBD alongside other cannabinoids and trace THC, supply a substantial share of revenue. A federal law scheduled to take effect in November 2026 would tighten THC limits in hemp consumables and may affect these products, although its implementation remains uncertain. Separately, the FDA's position against adding CBD to food or marketing it as a dietary supplement could restrict the company's operations if enforced.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in YCBD’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

YCBD says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer
  • Village Farms International, Inc. competes for cbdMD’s core online CBD customers through its Balanced Health Botanicals subsidiary, which sells hemp-derived CBD products under CBDistillery.

  • RYTHM, Inc. competes directly with cbdMD’s cannabinoid products and Herbal Oasis drinks by selling hemp-derived THC beverages and edibles to consumers online and through retailers. Watch the retail reach of its Señorita drinks for competition facing Herbal Oasis.

  • Organigram Global Inc. competes with cbdMD’s Herbal Oasis for U.S. consumers buying intoxicating hemp beverages through its Collective Project hemp-derived THC drinks.

  • Tilray Brands, Inc. competes with cbdMD’s Herbal Oasis for both consumers and beverage distribution through its U.S. hemp-derived THC drinks.

Agenda

in 20 daysMon, Nov 9

  1. Time to be announced

    Village Farms International, Inc. earningsVFF

    Village Farms' report will show how its CBDistillery online CBD business is doing, offering a read on its competition with cbdMD for online customers.

in 56 daysTue, Dec 15

  1. Time to be announced

    Organigram Global Inc. earningsOGI

    Organigram's report can show demand and retail reach for its Collective Project hemp-derived THC drinks in the U.S., a direct competitive signal for cbdMD's Herbal Oasis.

in 59 daysFri, Dec 18

  1. Time to be announced
    Major

    cbdMD, Inc. earningsThis company

    cbdMD's report will show whether wholesale sales keep growing, e-commerce sales stop falling, and gross profit gets closer to covering operating expenses.